Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Dr Sulaiman Al Habib Medical Services Group Company SJSC banner

Dr Sulaiman Al Habib Medical Services Group Company SJSC
SAU:4013

Watchlist Manager
Dr Sulaiman Al Habib Medical Services Group Company SJSC Logo
Dr Sulaiman Al Habib Medical Services Group Company SJSC
SAU:4013
Watchlist
Price: 280 SAR -0.5% Market Closed
Market Cap: ﷼98B
Write Note Create Alert Ask AI

Wall St Price Targets

Price Targets Summary
Dr Sulaiman Al Habib Medical Services Group Company SJSC

Wall Street analysts forecast Dr Sulaiman Al Habib Medical Services Group Company SJSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dr Sulaiman Al Habib Medical Services Group Company SJSC is 285.6 SAR with a low forecast of 251.79 SAR and a high forecast of 336 SAR.

Lowest Forecast
Wall Street Target
﷼251.79
-10% Downside
Average Forecast
Wall Street Target
﷼285.6
2% Upside
Highest Forecast
Wall Street Target
﷼336
20% Upside
Lowest Forecast
Price Target
251.79 SAR
10% Downside
Average Forecast
Price Target
285.6 SAR
2% Upside
Highest Forecast
Price Target
336 SAR
20% Upside
Dr Sulaiman Al Habib Medical Services Group Company SJSC Competitors:
Price Targets

Revenue
Forecast

17% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 5 years is 15%.

What are analyst estimates?

Gross Profit
Forecast

17% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 7 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 4 years is 14%.

What are analyst estimates?

Operating Income
Forecast

18% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
18% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 7 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 5 years is 15%.

What are analyst estimates?

Pre-Tax Income
Forecast

16% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
16% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 16%.

What are analyst estimates?

Net Income
Forecast

17% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 7 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 4 years is 14%.

What are analyst estimates?

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Dr Sulaiman Al Habib Medical Services Group Company SJSC's stock price target?
Price Target
285.6 SAR

According to Wall Street analysts, the average 1-year price target for Dr Sulaiman Al Habib Medical Services Group Company SJSC is 285.6 SAR with a low forecast of 251.79 SAR and a high forecast of 336 SAR.

What is the Revenue forecast for Dr Sulaiman Al Habib Medical Services Group Company SJSC?
Projected CAGR
15%

Over the last 7 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 5 years is 15%.

What is the Gross Profit forecast for Dr Sulaiman Al Habib Medical Services Group Company SJSC?
Projected CAGR
14%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 4 years is 14%.

What is the Operating Income forecast for Dr Sulaiman Al Habib Medical Services Group Company SJSC?
Projected CAGR
15%

Over the last 7 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 5 years is 15%.

What is the Pre-Tax Income forecast for Dr Sulaiman Al Habib Medical Services Group Company SJSC?
Projected CAGR
16%

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 16%.

What is the Net Income forecast for Dr Sulaiman Al Habib Medical Services Group Company SJSC?
Projected CAGR
14%

Over the last 7 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 4 years is 14%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.